ACE lecture One in every two diagnosed cancers is skin cancer Did you know that one in every two diagnosed cancers, is skin cancer? At the Erasmus MC Cancer Institute, a team is working on the best care for skin cancer patients.
Oncology Hepatitis B research with liver organoids shows: first signs of liver cancer visible at an early stage Organoids made from liver tissue of patients with chronic hepatitis B already show the first molecular signs of liver cancer. This has been demonstrated by scientists at Erasmus MC and the the Hubrecht Organoid Technology (HUB).
Liquid biopsies Searching among 5,685 substances for the next cancer drug In a joint research project with Delft University of Technology and Leiden University Medical Center, internist-oncologist Stefan Sleijfer is looking for a drug that can prevent cancer from spreading. Remarkable: the researchers are searching in a library of substances that are already used in daily practice.
Oncology Liquid biopsy contains wealth of information about cancer patient If the expression ‘looking for a needle in a haystack’ applies to anyone, it is to Prof. John Martens of the Erasmus MC Cancer Institute. He and his team search for fragments of cancer in body fluids. These liquid biopsies teach them a lot about cancer patients and their tumors.
Pembrolizumab Immune therapy prevents bladder removal for some bladder cancer patients A proportion of patients with difficult-to-treat non-metastatic bladder cancer benefit from immunotherapy with the drug pembrolizumab. This has been shown by international research, which Erasmus MC Cancer Institute co-led. Annually, researchers estimate this new therapy could save about 50 patients in the Netherlands from having their bladder removed.
Oncology More efficient cancer therapies possible: better for patient, healthcare costs, and environment Internist and oncologist Stefan Sleijfer and hospital pharmacist Roelof van Leeuwen of Erasmus MC Cancer Institute are working closely together to make cancer therapies more effective. This is not only good for patients, but also for public coffers and for the environment. These efforts save the department of Internal Oncology about EUR 7 million per […]
UFO Biosciences Advanced microscope finds cancer cells that matter Scientist Miao-Ping Chien and her team have designed and built a completely new type of microscope. In doing so, Chien hopes to boost research into rare cancer cells. ‘We can image tens of thousands of individual cells at once.’
Tailored cancer therapy The power of the combination Looking at both tumor and patient. “In tailored therapy the focus must lie on the tumor and on the patient,” says professor Ron Mathijssen of Erasmus MC Cancer Institute. “It is the knowledge of both that will make the therapy more effective.”
